JUMP REPORT
CHEWY, INC (CHWY)
EARNINGS RELEASE - SEPTEMBER 10 (AMC)
EARNINGS EXPECTATIONS:
THIS QTR: EPS: -.16/share REV: 1,690/M
___________________________________________________________
NEXT QTR: EPS: -.12/share REV: 1,700/M
____________________________________________________________
FULL YR: EPS: -.46/share REV: 6,850/M
____________________________________________________________
LAST QTR: EPS: -.16/share ACTUAL: -.12/share (BEAT)
____________________________________________________________
BEAT/MISS RECORD: 0% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) -5.78, 9.35, 7.91
EXPECTED JUMP MOVE THIS QUARTER: 8-10+%
——–
*** With market volatility at extremes there is greater risk in trading these events which may not react as they would under normal market conditions. Please take extra caution before trading.
Links To Latest News and Headlines
Chewy (NYSE:CHWY) has appointed Christopher S. Deppe as Chief Financial Officer. Deppe brings extensive finance leadership experience, including senior roles at Amazon and in corporate operations. The CFO transition is viewed as a material corporate event for Chewy’s financial management and planning. Chewy operates an online pet products and services business, a segment that has attracted attention as consumers increasingly buy pet food, supplies, and medications through digital channels…
NDT Pharmaceuticals Highlights Enhanced Omni-Channel Positioning; Sets Stage for 2026 Growth with Strategic Marketing Expansion NDT Pharmaceuticals, Inc.’s (OTC: NDTP) wholly owned subsidiary, Good Salt Life, Inc., is currently leveraging its presence across some of the world’s largest digital marketplaces, including Amazon, Chewy.com, and Walmart – www.goodsaltlife.com & www.ndtpharmaceuticals.com ATHENS, Ga., March 03, 2026 (GLOBE NEWSWIRE) — NDT Pharmaceuticals, Inc. (OTC: NDTP) (“Company”),
The pet retailer is on a path to growth, though a $100 per share price may be a lofty goal.
Chewy’s fair value estimate has been adjusted slightly, with the price target moving from US$44.95 to US$44.45 per share. That small trim sits alongside a broader reset in Street research, where some firms are turning more constructive after a 33% pullback while others are recalibrating expectations around 2026 sales, margins, and how internet peers are trading. The following sections outline how these shifting assumptions and narratives fit together so you can track where the story may go…
Chewy Inc. (NYSE:CHWY) is one of the stocks with explosive growth potential. On February 24, Chewy announced the appointment of Chris Deppe as its new Chief Financial Officer. Deppe, who joined the company in 2022, previously served as Vice President of Supply Chain & Operations Finance and most recently headed all Corporate and Commercial Finance […]
StockJumpers analysis and trade plans are finalized and uploaded generally one house before market cloase (3PM EST) for most events unless noticed.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is stripped down to only what is needed to make the best possible decision(s) on trading the trajectory.
Members who are too busy to manual trade can use Trade Assist. For more information visit here
Avg Daily Volume: 4,074,368 Market Cap: 22.97B
Sector: None Short Interest: 28.21
Ticker delayed 20 minutes
NOTICE: All material on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.